Regulation of Bone Mass Laboratory

Matthew B. Greenblatt, MD, PhD, Principal Investigator

Approximately half of all women and a fifth of all men will experience a skeletal fracture due to low bone mass. These fractures kill as many women each year as breast cancer. Improving clinical outcomes in this area will ultimately require finding new therapeutic agents that promote the activity of osteoblasts, the cells that build bone, which in turn will require improving our understanding of the molecular pathways involved in this process. To this end, we are focused on using a combination of genetics, cellular biochemistry and genome-wide screening to discover new molecular pathways that regulate the activity of osteoblasts. In particular, we are interested in how tuning the activity of the genes involved in the ability of osteoblasts to perceive signals from their environment can control the formation of bone, focusing on an ancient and fundamentally important family of signaling molecules, the mitogen activated protein kinases (MAPKs). Currently, we are exploring how dysregulation of MAPK signaling contributes to skeletal disease and how MAPK pathways can be targeted to benefit bone health.

Active Projects:

Currently, an area of focus in the lab is understanding how alterations in the signaling of mitogen activated protein kinases contribute to the development of both osteoporosis and rare skeletal disorders, with a particular emphasis on discovering approaches to target these pathways for therapeutic benefit in humans.

Active Grants:

Development of an Antibody Inhibitor of SLITRK5 for the Treatment of Osteoporosis
PI: Matthew Greenblatt, MD, PhD
Tri-Institutional Therapeutics Discovery Institute
Defining the role of a Novel Periosteal Mesenchymal Stem Cell in Skeletal Morphogenesis and Development
PI: Matthew Greenblatt, MD, PhD
March of Dimes Basil O’ Connor Starter Scholar Research Award
Novel Mechanisms of Bone Formation
PI: Matthew Greenblatt, MD, PhD
Burroughs Wellcome Fund Career Award for Medical Scientists
Modulation of Bone Formation by SHN3
PI: Matthew Greenblatt, MD, PhD
National Institutes of Health (NIH) Early Independence Award

Selected Publications

Expand All

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts

Matthew B. Greenblatt, MD, PhD

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts

J Exp Med. 2015 Jul 27;212(8):1283-301.

Greenblatt MB, Park KH, Oh H, Kim JM, Shin DY, Lee JM, Lee JW, Singh A, Lee KY, Hu D, Xiao C, Charles JF, Penninger JM, Lotinun S, Baron R, Ghosh S, Shim JH.

PMID: 26195726; PMCID: PMC4516796

Impact of a prospective review program for reference laboratory testing requests

Matthew B. Greenblatt, MD, PhD

Impact of a prospective review program for reference laboratory testing requests

Am J Clin Pathol. 2015 May;143(5):627-34.

Greenblatt MB, Nowak JA, Quade CC, Tanasijevic M, Lindeman N, Jarolim P.

PMID: 25873495

p38α MAPK is required for tooth morphogenesis and enamel secretion

Matthew B. Greenblatt, MD, PhD

p38α MAPK is required for tooth morphogenesis and enamel secretion

J Biol Chem. 2015 Jan 2;290(1):284-95

Greenblatt MB, Kim JM, Oh H, Park KH, Choo MK, Sano Y, Tye CE, Skobe Z, Davis RJ, Park JM, Bei M, Glimcher LH, Shim JH.

PMID: 25406311; PMCID: PMC4281732.

Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction

Matthew B. Greenblatt, MD, PhD

Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction

Clin Chem. 2014 Nov;60(11):1453-5.

Greenblatt MB, Torre M, Means J, Tanasijevic M, Vitale Pedulla L, Bunnell CA, Conrad MJ, Jarolim P.

PMID: 25161146

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

Matthew B. Greenblatt, MD, PhD

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

Nature. 2014 Apr 3;508(7494):103-7.

Chen X, Iliopoulos D, Zhang Q, Tang Q, Greenblatt MB, Hatziapostolou M, Lim E, Tam WL, Ni M, Chen Y, Mai J, Shen H, Hu DZ, Adoro S, Hu B, Song M, Tan C, Landis MD, Ferrari M, Shin SJ, Brown M, Chang JC, Liu XS, Glimcher LH.

PMID: 24670641; PMCID: PMC4105133

S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway

Matthew B. Greenblatt, MD, PhD

S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway

Mol Cell Biol. 2014 Feb;34(3):510-21.

Kim SY, Baik KH, Baek KH, Chah KH, Kim KA, Moon G, Jung E, Kim ST, Shim JH, Greenblatt MB, Chun E, Lee KY.

PMID: 24277938; PMCID: PMC3911500

NFATc1 and NFATc2 repress spontaneous osteoarthritis

Matthew B. Greenblatt, MD, PhD

NFATc1 and NFATc2 repress spontaneous osteoarthritis

Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19914-9.

Greenblatt MB, Ritter SY, Wright J, Tsang K, Hu D, Glimcher LH, Aliprantis AO.

PMID: 24248346; PMCID: PMC3856808

Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts

Matthew B. Greenblatt, MD, PhD

Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts

J Clin Invest. 2013 Sep;123(9):4010-22.

Shim JH, Greenblatt MB, Zou W, Huang Z, Wein MN, Brady N, Hu D, Charron J, Brodkin HR, Petsko GA, Zaller D, Zhai B, Gygi S, Glimcher LH, Jones DC.

PubMed PMID: 23945236; PMCID: PMC3754267

The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2

Matthew B. Greenblatt, MD, PhD

The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2

J Exp Med. 2013 Aug 26;210(9):1793-806.

Zou W, Greenblatt MB, Brady N, Lotinun S, Zhai B, de Rivera H, Singh A, Sun J, Gygi SP, Baron R, Glimcher LH, Jones DC.

PMID: 23918955; PMCID: PMC3754873

Osteoimmunology: a brief introduction

Matthew B. Greenblatt, MD, PhD

Osteoimmunology: a brief introduction

Immune Netw. 2013 Aug;13(4):111-5.

Greenblatt MB, Shim JH.

PMID: 24009537; PMCID: PMC3759707

Mitogen-activated protein kinase pathways in osteoblasts

Matthew B. Greenblatt, MD, PhD

Mitogen-activated protein kinase pathways in osteoblasts

Annu Rev Cell Dev Biol. 2013;29:63-79.

Greenblatt MB, Shim JH, Glimcher LH.

PMID: 23725048

The immune pathogenesis of scleroderma: context is everything

Matthew B. Greenblatt, MD, PhD

The immune pathogenesis of scleroderma: context is everything

Curr Rheumatol Rep. 2013 Jan;15(1):297.

Greenblatt MB, Aliprantis AO.

PMID: 23288576; PMCID: PMC3539168

A TAK1/p38 Signaling Axis Regulates RUNX2 Activity and Osteoblast Functions

Matthew B. Greenblatt, MD, PhD

A TAK1/p38 Signaling Axis Regulates RUNX2 Activity and Osteoblast Functions

Greenblatt MB, Shim JH, Zou WG, Glimcher LH.

In: Choi YW, editor. Osteoimmunology: Interactions of the Immune and Skeletal Systems.

New York: Springer New York; 2013. p.49-56.

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

Matthew B. Greenblatt, MD, PhD

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

Am J Pathol. 2012 Mar;180(3):1080-94.

Greenblatt MB, Sargent JL, Farina G, Tsang K, Lafyatis R, Glimcher LH, Whitfield ML, Aliprantis AO.

PMID: 22245215; PMCID: PMC3349888

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice

Matthew B. Greenblatt, MD, PhD

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice

J Clin Invest. 2012 Jan;122(1):91-106.

Shim JH, Greenblatt MB, Singh A, Brady N, Hu D, Drapp R, Ogawa W, Kasuga M, Noda T, Yang SH, Lee SK, Rebel VI, Glimcher LH.

Erratum in: J Clin Invest. 2012 May 1;122(5):1948.

PMID: 22133875; PMCID: PMC3248303

Graft versus host disease in the bone marrow, liver and thymus humanized mouse model

Matthew B. Greenblatt, MD, PhD

Graft versus host disease in the bone marrow, liver and thymus humanized mouse model

PLoS One. 2012;7(9):e44664.

Greenblatt MB, Vrbanac V, Tivey T, Tsang K, Tager AM, Aliprantis AO.

Erratum in: PLoS One. 2013;8(5). Vbranac, Vladimir [corrected to Vrbanac, Vladimir].

PMID: 22957096; PMCID: PMC3434179.

MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice

Matthew B. Greenblatt, MD, PhD

MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice

J Clin Invest. 2011 Nov;121(11):4383-92.

Zou W, Greenblatt MB, Shim JH, Kant S, Zhai B, Lotinun S, Brady N, Hu DZ, Gygi SP, Baron R, Davis RJ, Jones D, Glimcher LH.

PMID: 21965325; PMCID: PMC3204846

Derlin-2-deficient mice reveal an essential role for protein dislocation in chondrocytes

Matthew B. Greenblatt, MD, PhD

Derlin-2-deficient mice reveal an essential role for protein dislocation in chondrocytes

Mol Cell Biol. 2011 Mar;31(6):1145-59.

Dougan SK, Hu CC, Paquet ME, Greenblatt MB, Kim J, Lilley BN, Watson N, Ploegh HL.

PMID: 21220515; PMCID: PMC3067910

The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice

Matthew B. Greenblatt, MD, PhD

The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice

J Clin Invest. 2010 Jul;120(7):2457-73.

Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, Arthur S, Xie M, Schneider MD, Zhai B, Gygi S, Davis R, Glimcher LH.

PMID: 20551513; PMCID: PMC2898605

Calcineurin regulates innate antifungal immunity in neutrophils

Matthew B. Greenblatt, MD, PhD

Calcineurin regulates innate antifungal immunity in neutrophils

J Exp Med. 2010 May 10;207(5):923-31.

Greenblatt MB, Aliprantis A, Hu B, Glimcher LH.

PMID: 20421389; PMCID: PMC2867274

TAK1 mediates BMP signaling in cartilage

Matthew B. Greenblatt, MD, PhD

TAK1 mediates BMP signaling in cartilage

Ann N Y Acad Sci. 2010 Mar;1192:385-90.

Greenblatt MB, Shim JH, Glimcher LH.

PMID: 20392264; PMCID: PMC3096020

TAK1 is an essential regulator of BMP signalling in cartilage

Matthew B. Greenblatt, MD, PhD

TAK1 is an essential regulator of BMP signalling in cartilage

EMBO J. 2009 Jul 22;28(14):2028-41.

Shim JH, Greenblatt MB, Xie M, Schneider MD, Zou W, Zhai B, Gygi S, Glimcher LH.

PMID: 19536134; PMCID: PMC2699391

A toll-like receptor that prevents infection by uropathogenic bacteria

Matthew B. Greenblatt, MD, PhD

A toll-like receptor that prevents infection by uropathogenic bacteria

Science. 2004 Mar 5;303(5663):1522-6.

Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S.

PMID: 15001781

You are here

Explore

Matthew B. Greenblatt, MD, PhD, Principal Investigator

Active Projects:

Active Grants:

Selected Publications

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts

Impact of a prospective review program for reference laboratory testing requests

p38α MAPK is required for tooth morphogenesis and enamel secretion

Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway

NFATc1 and NFATc2 repress spontaneous osteoarthritis

Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts

The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2

Osteoimmunology: a brief introduction

Mitogen-activated protein kinase pathways in osteoblasts

The immune pathogenesis of scleroderma: context is everything

A TAK1/p38 Signaling Axis Regulates RUNX2 Activity and Osteoblast Functions

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice

Graft versus host disease in the bone marrow, liver and thymus humanized mouse model

MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice

Derlin-2-deficient mice reveal an essential role for protein dislocation in chondrocytes

The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice

Calcineurin regulates innate antifungal immunity in neutrophils

TAK1 mediates BMP signaling in cartilage

TAK1 is an essential regulator of BMP signalling in cartilage

A toll-like receptor that prevents infection by uropathogenic bacteria

Faculty

You are here

Explore

Regulation of Bone Mass Laboratory

Matthew B. Greenblatt, MD, PhD, Principal Investigator

Active Projects:

Active Grants:

Selected Publications

CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts

Impact of a prospective review program for reference laboratory testing requests

p38α MAPK is required for tooth morphogenesis and enamel secretion

Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction

XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway

NFATc1 and NFATc2 repress spontaneous osteoarthritis

Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts

The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2

Osteoimmunology: a brief introduction

Mitogen-activated protein kinase pathways in osteoblasts

The immune pathogenesis of scleroderma: context is everything

A TAK1/p38 Signaling Axis Regulates RUNX2 Activity and Osteoblast Functions

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets

Administration of BMP2/7 in utero partially reverses Rubinstein-Taybi syndrome-like skeletal defects induced by Pdk1 or Cbp mutations in mice

Graft versus host disease in the bone marrow, liver and thymus humanized mouse model

MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice

Derlin-2-deficient mice reveal an essential role for protein dislocation in chondrocytes

The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice

Calcineurin regulates innate antifungal immunity in neutrophils

TAK1 mediates BMP signaling in cartilage

TAK1 is an essential regulator of BMP signalling in cartilage

A toll-like receptor that prevents infection by uropathogenic bacteria

Related Links

General Contact

Faculty